Sleep Aids Market 2022
New Study Reports “Sleep Aids Market 2022 Global Sizing and Growth, Dynamics, Competitive Landscape, SWOT Analysis and Forecasts 2031” has been Added on PMR.
Market Overview
In the past few years, The primary focus of the report is on the status, demand, future opportunity, forecast period, and growth opportunity. Moreover, the survey report focuses on the development, manufacturing companies, key market, investors, and the cost capital. The objective of the study of Sleep Aids Market gives a proper idea of the market present scenario so that each and every enterprise or manufacturer will not experience the issues that occur due to the lack of information.
Increasing prevalence of sleep-related disorders, changing lifestyles, obesity, and increasing aging population, together with technology advancements with the launch of innovative devices are some of the factors driving demand for sleep aids.
Get Free Sample Of Sleep Aids Market Report@ https://www.persistencemarketresearch.com/samples/2832
Increasing demand for sleeping pills due to modern lifestyles is one of the major factor driving demand for sleep aids. Stressful pace of life is found to be the main characteristic of modern lifestyle, thus increasing the incidence of sleep-related disorders. According to the Centers for Disease Control and Prevention (CDC) 2020 report, one-third of the U.S. population gets less than the recommended amount of sleep on a regular basis.
Company Profiles:
- ResMed Inc.
- Royal Philips NV
- Merck & Co. Inc.
- Drive DeVilbiss Healthcare LLC
- GlaxoSmithKline Plc.
- Fisher & Paykel Healthcare Limited
- Sanofi SA
- Pfizer Inc
Key Takeaways from Market Study
- By product, mattresses and pillows, chin straps, mouth pieces, and nasal devices will hold a market share of 72.5% in 2021, expanding at a CAGR of around 4.3% over the forecast period.
- By indication, insomnia is expected to hold well over 35% market share in 2021, and is expected to continue growing at a moderate rate over the forecast period.
- By distribution channel, the e-Commerce and others segments together holds more than 50% market share, and are expected to continue a similar trend through the forecast period.
- By region, North America held the highest share in the global market in 2020, with the market expanding at a CAGR of nearly 4%.
“Growing incidence of sleeping disorders and rising need for technologically advanced products for their treatment are expected to drive market growth over the forecast period,” says an analyst of Persistence Market Research.
Look Through The “Methodology” Employed@ https://www.persistencemarketresearch.com/methodology/2832
Market Competition
New product launches and acquisitions have emerged as a key growth strategy adopted by some of the leading manufacturers of sleep aids. By focusing on these strategies, key stakeholders are expanding their geographic footprints and strengthening their existing product portfolios.
- 04-Feb-2020, Merck & Co/MSD claimed FDA approval for a new use of its insomnia drug Belsomra, treating sleep disruption in people with mild-to-moderate Alzheimer’s disease.
- In January 2019, GSK announced that it completed the acquisition of Tesaro for approximately US$ 5.1 Bn.
- In 2018, Philips acquired NightBalance, a digital health company in the Netherlands, which has developed an innovative, easy-to-use device to treat positional obstructive sleep apnea and positional snoring.
- In August 2017, Sanofi S.A. announced the acquisition of Protein Sciences, a vaccines biotechnology company based in Meriden, Connecticut, in the United States.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the sleep aids market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on product (drugs {insomnia treatment drugs [doxepin hydrochloride, eszopiclone, ramelteon, triazolam, zaleplon, quazepam, and others], narcolepsy treatment drugs [modafinil, sodium oxybate, armodafinil, and others]}, devices {CPAP devices, BIPAP devices, and APAP devices}, others {mattresses & pillows, chin straps, nasal devices and mouthpieces}), by indication (insomnia, sleep deprivation, narcolepsy, sleep apnea, and others), and distribution channel (hospital pharmacies, retail pharmacies, e-Commerce, drug stores, and others), across five key regions of the world.
Sleep Aids Market – Report Highlights
- A detailed overview of parent market of Sleep Aids Market
- Changing Sleep Aids Market dynamics in the industry
- In-depth segmentation of the Sleep Aids Market
- Historical, current, and projected Sleep Aids Market size regarding volume and value
- Recent industry trends and developments in Sleep Aids Market
- Competitive landscape of the Sleep Aids Market
- Strategies for key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on Sleep Aids Market performance
- Must-have information for Sleep Aids Market players to sustain and enhance their market footprint
Purchase Our Sleep Aids Market Report Now!@ https://www.persistencemarketresearch.com/checkout/2832
About Us: – Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com